Form 4 Tracker
VERACYTE, INC.
VCYT

25 insider filings · Latest: Jun 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 4, 2026Jun 5 1:38 AMAnnie McguireEVP, General Counsel
Sale
3,176$49.76$158.0K137,240(D)

View →

Jun 4, 2026Jun 5 1:38 AMRebecca ChambersChief Financial Officer
Sale
3,561$49.73$177.1K173,280(D)

View →

Jun 4, 2026Jun 5 1:38 AMMarc StapleyDirector, Chief Executive Officer
Sale
138,051$50.12$6.9M440,494(D)

View →

Jun 4, 2026Jun 5 1:38 AMJohn LeiteGlobal Chief Commercial Off
Sale
13,975$50.07$699.7K132,305(D)

View →

May 22, 2026May 27 8:19 PMJonathan WygantVP, Chief Accounting Officer
Sale
24,000$45.40$1.1M45,434(D)

View →

May 20, 2026May 22 8:39 PMRobert S EpsteinDirector
Sale
10,000$44.01$440.1K52,446(D)

View →

May 6, 2026May 8 8:25 PMAnnie McguireSVP, General Counsel
Sale
10,204$39.03$398.2K143,708(D)

View →

Mar 4, 2026Mar 6 9:33 PMRebecca ChambersChief Financial Officer
Sale
18,341$36.14$662.9K131,196(D)

View →

Mar 4, 2026Mar 6 9:32 PMMarc StapleyDirector, Chief Executive Officer
Sale
45,523$35.97$1.6M357,554(D)

View →

Mar 4, 2026Mar 6 9:32 PMJohn LeiteChief Commercial Officer-CLIA
Sale
5,260$35.19$185.1K107,580(D)

View →

Mar 4, 2026Mar 6 9:32 PMAnnie McguireSVP, General Counsel
Sale
6,658$35.55$236.7K94,706(D)

View →

Mar 2, 2026Mar 4 9:16 PMPhillip G. FebboChief Scientific & Med Officer
Sale
13,425$36.16$485.4K117,346(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 5 1:38 AMMarc StapleyDirector, Chief Executive Officer
Option Exercise
138,051$36.600(D)

View →

May 22, 2026May 27 8:19 PMJonathan WygantVP, Chief Accounting Officer
Option Exercise
24,000$24.800(D)

View →